Effect of norgestrel on development of mouse pre-embryos

Julia Logan, Michael Peter Diamond, Gad Lavy, Alan H. DeCherney

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The effect of synthetic progestins found in oral contraceptives has potential implications for developing embryos in women who receive oral contraceptives during early pregnancy. We assessed the effect of the progestin norgestrel on the developing pre-embryo. B3C6F1 mice were given 5 IU PMSG followed by 5 IU hCG 48h later. Studies were performed on pre-embryos recovered and pooled at both 24h (Group A) and 48h (Group B) post hCG. At each time period, they were randomly assigned to control or norgestrel (4.0 ng/ml) treatment. In a third study, pre-embryos collected 24h post hCG were cultured in the absence or presence of 8.0, 80.0, or 800 ng/ml norgestrel. Cultures were performed in Ham's F-10 media with 10% fetal calf serum at 37 °C in an atmosphere of 5% CO2, 5% O2 and 90% N2 with 15-30 embryos per 1 ml of culture fluid. At 24h, 48h and 72h post recovery, cultures were viewed, the appearance of embryos noted, and number of blastomeres recorded. Compared to control groups, analysis demonstrated no significant difference in the rate of development of control and norgestrel pre-embryos in any group at any time period (24h, 48h, or 72h post recovery). We conclude that norgestrel at the dose tested has no acute adverse morphological effects on development of mouse pre-embryos. This observation has potential clinical implications with regard to inadvertent use of norgestrel-containing oral contraceptives during early days of pregnancy, as well as consideration of the mechanism of action of norgestrel-containing "morning after" pills.

Original languageEnglish (US)
Pages (from-to)555-561
Number of pages7
JournalContraception
Volume39
Issue number5
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Norgestrel
Embryonic Structures
Oral Contraceptives
Postcoital Contraceptives
Progesterone Congeners
Blastomeres
Pregnancy
Progestins
Atmosphere
Control Groups

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Effect of norgestrel on development of mouse pre-embryos. / Logan, Julia; Diamond, Michael Peter; Lavy, Gad; DeCherney, Alan H.

In: Contraception, Vol. 39, No. 5, 01.01.1989, p. 555-561.

Research output: Contribution to journalArticle

Logan, Julia ; Diamond, Michael Peter ; Lavy, Gad ; DeCherney, Alan H. / Effect of norgestrel on development of mouse pre-embryos. In: Contraception. 1989 ; Vol. 39, No. 5. pp. 555-561.
@article{047a2c690da640cfa28a7444171ac593,
title = "Effect of norgestrel on development of mouse pre-embryos",
abstract = "The effect of synthetic progestins found in oral contraceptives has potential implications for developing embryos in women who receive oral contraceptives during early pregnancy. We assessed the effect of the progestin norgestrel on the developing pre-embryo. B3C6F1 mice were given 5 IU PMSG followed by 5 IU hCG 48h later. Studies were performed on pre-embryos recovered and pooled at both 24h (Group A) and 48h (Group B) post hCG. At each time period, they were randomly assigned to control or norgestrel (4.0 ng/ml) treatment. In a third study, pre-embryos collected 24h post hCG were cultured in the absence or presence of 8.0, 80.0, or 800 ng/ml norgestrel. Cultures were performed in Ham's F-10 media with 10{\%} fetal calf serum at 37 °C in an atmosphere of 5{\%} CO2, 5{\%} O2 and 90{\%} N2 with 15-30 embryos per 1 ml of culture fluid. At 24h, 48h and 72h post recovery, cultures were viewed, the appearance of embryos noted, and number of blastomeres recorded. Compared to control groups, analysis demonstrated no significant difference in the rate of development of control and norgestrel pre-embryos in any group at any time period (24h, 48h, or 72h post recovery). We conclude that norgestrel at the dose tested has no acute adverse morphological effects on development of mouse pre-embryos. This observation has potential clinical implications with regard to inadvertent use of norgestrel-containing oral contraceptives during early days of pregnancy, as well as consideration of the mechanism of action of norgestrel-containing {"}morning after{"} pills.",
author = "Julia Logan and Diamond, {Michael Peter} and Gad Lavy and DeCherney, {Alan H.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0010-7824(89)90110-8",
language = "English (US)",
volume = "39",
pages = "555--561",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Effect of norgestrel on development of mouse pre-embryos

AU - Logan, Julia

AU - Diamond, Michael Peter

AU - Lavy, Gad

AU - DeCherney, Alan H.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The effect of synthetic progestins found in oral contraceptives has potential implications for developing embryos in women who receive oral contraceptives during early pregnancy. We assessed the effect of the progestin norgestrel on the developing pre-embryo. B3C6F1 mice were given 5 IU PMSG followed by 5 IU hCG 48h later. Studies were performed on pre-embryos recovered and pooled at both 24h (Group A) and 48h (Group B) post hCG. At each time period, they were randomly assigned to control or norgestrel (4.0 ng/ml) treatment. In a third study, pre-embryos collected 24h post hCG were cultured in the absence or presence of 8.0, 80.0, or 800 ng/ml norgestrel. Cultures were performed in Ham's F-10 media with 10% fetal calf serum at 37 °C in an atmosphere of 5% CO2, 5% O2 and 90% N2 with 15-30 embryos per 1 ml of culture fluid. At 24h, 48h and 72h post recovery, cultures were viewed, the appearance of embryos noted, and number of blastomeres recorded. Compared to control groups, analysis demonstrated no significant difference in the rate of development of control and norgestrel pre-embryos in any group at any time period (24h, 48h, or 72h post recovery). We conclude that norgestrel at the dose tested has no acute adverse morphological effects on development of mouse pre-embryos. This observation has potential clinical implications with regard to inadvertent use of norgestrel-containing oral contraceptives during early days of pregnancy, as well as consideration of the mechanism of action of norgestrel-containing "morning after" pills.

AB - The effect of synthetic progestins found in oral contraceptives has potential implications for developing embryos in women who receive oral contraceptives during early pregnancy. We assessed the effect of the progestin norgestrel on the developing pre-embryo. B3C6F1 mice were given 5 IU PMSG followed by 5 IU hCG 48h later. Studies were performed on pre-embryos recovered and pooled at both 24h (Group A) and 48h (Group B) post hCG. At each time period, they were randomly assigned to control or norgestrel (4.0 ng/ml) treatment. In a third study, pre-embryos collected 24h post hCG were cultured in the absence or presence of 8.0, 80.0, or 800 ng/ml norgestrel. Cultures were performed in Ham's F-10 media with 10% fetal calf serum at 37 °C in an atmosphere of 5% CO2, 5% O2 and 90% N2 with 15-30 embryos per 1 ml of culture fluid. At 24h, 48h and 72h post recovery, cultures were viewed, the appearance of embryos noted, and number of blastomeres recorded. Compared to control groups, analysis demonstrated no significant difference in the rate of development of control and norgestrel pre-embryos in any group at any time period (24h, 48h, or 72h post recovery). We conclude that norgestrel at the dose tested has no acute adverse morphological effects on development of mouse pre-embryos. This observation has potential clinical implications with regard to inadvertent use of norgestrel-containing oral contraceptives during early days of pregnancy, as well as consideration of the mechanism of action of norgestrel-containing "morning after" pills.

UR - http://www.scopus.com/inward/record.url?scp=0024500454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024500454&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(89)90110-8

DO - 10.1016/0010-7824(89)90110-8

M3 - Article

C2 - 2721199

AN - SCOPUS:0024500454

VL - 39

SP - 555

EP - 561

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -